Intracellular β2AR signaling is involved in the modulation of tumorigenesis and tumor progression [46,48], and has been identified as a target to regulate cancer progression [18,46], especially in breast cancer and gastric cancer [49,50,51]. Here, ADRB2 is linked to breast carcinoma.